Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | SVP, Corporate Controller | May 15, 2025 | May 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date May 15, 2025 · Filed May 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 121,921 |
Reported balance
After 2025-05-15 transaction · row 1
1 source rowRow 1 · 2025-05-15 · Tax withholding · Disposed 1,533 · Balance 121,921 F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2025 Filed May 16, 2025 20:10 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 1,533 | $7.00 | $10,731.00 |
DisclosureSEC source: 0001062993-25-009651 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,921 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 23:39 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 1,059 | $10.09 | $10,685.31 |
DisclosureSEC source: 0001062993-25-006164 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,454 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:40 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 28,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004573 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,513 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:40 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 19,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-013406 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,347 F1 · security: Restricted stock grant with three year cliff vesting. Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:00 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 2,077 | $19.78 | $41,083.06 |
DisclosureSEC source: 0001062993-24-010497 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,145 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 01:37 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 3,086 | $24.99 | $77,119.14 |
DisclosureSEC source: 0001062993-24-006696 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,222 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 10,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005531 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,308 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 01:00 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 10,000 | $25.00 | $250,000.00 |
DisclosureSEC source: 0001062993-24-004866 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,654 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 7, 2023. Read SEC document |
| December 29, 2023 Filed Jan 18, 2024 13:51 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 555 | $16.18 | $8,982.12 |
DisclosureSEC source: 0001062993-24-000993 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,654 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 22:41 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 739 | $16.24 | $11,997.67 |
DisclosureSEC source: 0001062993-23-014520 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,099 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 10,000 | $21.11 | $211,100.00 |
DisclosureSEC source: 0001062993-23-013178 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,360 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 7, 2023. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:06 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 928 | $18.73 | $17,381.44 |
DisclosureSEC source: 0001062993-23-011356 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,360 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 11, 2023 Filed May 12, 2023 13:03 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 1,453 | $18.39 | $26,720.67 |
DisclosureSEC source: 0001062993-23-010874 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,288 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 21:18 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 8,923 | $13.06 | $116,534.38 |
DisclosureSEC source: 0001062993-23-007080 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,741 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:00 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 10,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005699 · form4.xml · nonDerivative · entry 2 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,664 F2 · security: .Restricted stock which vests on March 15, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:00 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 11,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005699 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,412 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 21:33 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 726 | $16.52 | $11,996.42 |
DisclosureSEC source: 0001062993-23-000308 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,077 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| May 16, 2022 Filed May 17, 2022 20:06 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 786 | $36.05 | $28,335.30 |
DisclosureSEC source: 0001062993-22-012723 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,351 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 11, 2022 Filed May 12, 2022 21:19 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 2,176 | $37.62 | $81,861.12 |
DisclosureSEC source: 0001062993-22-012285 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,137 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 23:55 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 21,058 | $42.77 | $900,650.66 |
DisclosureSEC source: 0001062993-22-007020 · form4.xml · nonDerivative · entry 2 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,313 F2 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 23:55 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 4,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-007020 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,371 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:44 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 29,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-003846 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,279 F1 · security: Restricted stock which vests on March 15, 2023. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 1,348 | $45.32 | $61,096.75 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 15 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,037 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F16 · price: Weighted average of the sale price range of $45.07 through $45.53 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 1,200 | $44.22 | $53,064.00 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 14 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,385 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F15 · price: Weighted average of the sale price range of $43.74 through $44.73 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 2,500 | $42.95 | $107,375.00 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 13 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,585 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F14 · price: Weighted average of the sale price range of $42.74 through $43.68 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 4,104 | $42.35 | $173,792.09 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 12 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,085 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F13 · price: Weighted average of the sale price range of $41.74 through $42.71 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 6,452 | $41.44 | $267,338.62 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 11 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,189 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F12 · price: Weighted average of the sale price range of $40.68 through $41.55 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 5,169 | $41.33 | $213,655.45 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 10 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,641 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F11 · price: Weighted average of the sale price range of $41.26 through $41.55 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 517 | $45.19 | $23,361.68 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 9 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,810 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F10 · price: Weighted average of the sale price range of $44.59 through $45.43 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 400 | $43.86 | $17,543.20 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 8 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,327 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F9 · price: Weighted average of the sale price range of $43.39 through $44.11 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 1,500 | $42.62 | $63,928.50 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 7 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,727 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F8 · price: Weighted average of the sale price range of $42.20 through $42.98 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 4,261 | $41.43 | $176,550.27 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 6 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,227 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F7 · price: Weighted average of the sale price range of $41.12 through $42.11 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 138 | $45.30 | $6,251.26 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 5 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,488 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F6 · price: Weighted average of the sale price range of $45.21 through $45.32 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 184 | $44.24 | $8,140.71 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 4 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,626 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F5 · price: Weighted average of the sale price range of $43.97 through $44.78 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 501 | $42.75 | $21,419.75 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 3 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,810 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F4 · price: Weighted average of the sale price range of $42.53 through $43.20 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 883 | $41.64 | $36,768.12 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 2 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,311 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F3 · price: Weighted average of the sale price range of $41.41 through $42.34 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 3,474 | $41.33 | $143,594.32 |
DisclosureSEC source: 0001062993-21-010279 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,194 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F2 · price: Weighted average of the sale price range of $41.26 through $41.55 Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 21:08 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 5,000 | $38.63 | $193,150.00 |
DisclosureSEC source: 0000075252-21-000138 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,668 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 12:35 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 5,487 | $44.71 | $245,323.77 |
DisclosureSEC source: 0000075252-21-000119 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,668 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| May 17, 2021 Filed May 18, 2021 21:15 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 2,963 | $31.84 | $94,341.92 |
DisclosureSEC source: 0000075252-21-000108 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,155 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| May 11, 2021 Filed May 13, 2021 12:58 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 1,497 | $33.41 | $50,014.77 |
DisclosureSEC source: 0000075252-21-000100 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,118 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 14:16 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 2,423 | $31.89 | $77,269.47 |
DisclosureSEC source: 0000075252-21-000059 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,615 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:52 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 5,126 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000052 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,038 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:11 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 46,574 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000020 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,912 F1 · security: Restricted stock which vests on March 4, 2022. Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 22:43 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 107 | $29.23 | $3,127.61 |
DisclosureSEC source: 0000075252-21-000013 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,338 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| December 07, 2020 Filed Dec 8, 2020 21:28 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 3,991 | $25.22 | $100,653.02 |
DisclosureSEC source: 0000075252-20-000152 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,445 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:10 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 10,000 | $22.22 | $222,200.00 |
DisclosureSEC source: 0000075252-20-000138 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,436 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 13:40 UTC Amendment | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 10,000 | $22.22 | $222,200.00 |
DisclosureSEC source: 0000075252-20-000141 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,436 Read SEC document |
| May 18, 2020 Filed May 19, 2020 12:26 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 735 | $6.83 | $5,020.05 |
DisclosureSEC source: 0000075252-20-000080 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,436 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:09 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 14,621 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000069 · edgar.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,171 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.